This Type Of Vitamin E Could Predict Your Risk For Alzheimer's—And You're Probably Not Getting Enough Of It

Vitamin E is essential for normal neurological function, according to a 2013 Journal of Internal Medicine study, which found that low levels of some types of the vitamin could help predict your risk for Alzheimer's disease. Looking to take back control of your health? 

Some types? That's right: There are different types of vitamin E. In fact, there are 8 varieties or "isoforms" of E, and research suggests your brain needs all of them for optimal health and function.

Read more: This Type Of Vitamin E Could Predict Your Risk For Alzheimer's—And You're Probably Not Getting Enough Of It

Source: msn.com/en-us/health/nutrition

Watch Slides Video: 9 Ways To Control Your Risk Of Alzheimer's

Serum Albumin Levels Associated with Mortality in Hemodialysis Patients

Serum albumin is commonly used as a proxy for nutritional status, as well as a marker of inflammation and a low serum albumin concentration is not only indicative of protein energy wasting in dialysis patients, but it is also a powerful predictor of the mortality risk in this population.

Several clinical conditions are associated with low serum albumin levels in dialysis patients, including infectious and inflammatory diseases, fluid overload, inadequate dialysis, severe co-morbidity, and taste change. Therefore, regular monitoring of serum albumin levels is useful for predicting outcomes in dialysis patients.

Read more: Enlarged Prostate: Molecular Mechanism Clue May Explain Link To Inflammation

The Hitachi 7600–210 modular clinical biochemistry analyzer (Photo courtesy of Hitachi).

Source: labmedica

New 'Mutation-Tracking' Blood Test Could Predict Breast Cancer Relapse Months in Advance

Scientists have developed a blood test for breast cancer able to identify which patients will suffer a relapse after treatment, months before tumours are visible on hospital scans.

The test can uncover small numbers of residual cancer cells that have resisted therapy by detecting cancer DNA in the bloodstream.

Researchers at The Institute of Cancer Research, London, and The Royal Marsden NHS Foundation Trust were able to track key mutations that cancer accumulates as it develops and spreads, without the need for invasive biopsy procedures.

They hope that by deciphering the DNA code found in blood samples, it should be possible to identify the particularly mutations likely to prove lethal to that patient - and tailor treatment accordingly.

Read more: New 'Mutation-Tracking' Blood Test Could Predict Breast Cancer Relapse Months in Advance

Source: medicalxpress